

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.05514404 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.05514404 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.63873181 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.62445035 |
| 5 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.84257235 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70070535 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70070535 |
| 8 | oxaloacetate metabolic process (GO:0006107) | 3.53913858 |
| 9 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51944938 |
| 10 | tricarboxylic acid cycle (GO:0006099) | 3.51153854 |
| 11 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51091094 |
| 12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.50995291 |
| 13 | DNA deamination (GO:0045006) | 3.48750502 |
| 14 | negative regulation of phagocytosis (GO:0050765) | 3.38864542 |
| 15 | NADH metabolic process (GO:0006734) | 3.28936582 |
| 16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26505373 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.21018091 |
| 18 | fatty acid beta-oxidation (GO:0006635) | 3.20873173 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.18374857 |
| 20 | B cell mediated immunity (GO:0019724) | 3.15113364 |
| 21 | cellular response to zinc ion (GO:0071294) | 3.12255283 |
| 22 | oxidative phosphorylation (GO:0006119) | 3.08016847 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05036556 |
| 24 | endosome to pigment granule transport (GO:0043485) | 3.04226550 |
| 25 | endosome to melanosome transport (GO:0035646) | 3.04226550 |
| 26 | tricarboxylic acid metabolic process (GO:0072350) | 3.03974491 |
| 27 | fatty acid transmembrane transport (GO:1902001) | 3.02467055 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.97684067 |
| 29 | pentose-phosphate shunt (GO:0006098) | 2.97637392 |
| 30 | carnitine shuttle (GO:0006853) | 2.95933044 |
| 31 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.95503288 |
| 32 | regulation of sequestering of triglyceride (GO:0010889) | 2.93732548 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.93120720 |
| 34 | valine metabolic process (GO:0006573) | 2.91097327 |
| 35 | negative regulation of B cell apoptotic process (GO:0002903) | 2.90636298 |
| 36 | carnitine metabolic process (GO:0009437) | 2.86418528 |
| 37 | definitive hemopoiesis (GO:0060216) | 2.86314999 |
| 38 | response to interferon-beta (GO:0035456) | 2.86221349 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 2.85950906 |
| 40 | lysine metabolic process (GO:0006553) | 2.85692192 |
| 41 | lysine catabolic process (GO:0006554) | 2.85692192 |
| 42 | viral transcription (GO:0019083) | 2.85414650 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.84185635 |
| 44 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.84097374 |
| 45 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.84097374 |
| 46 | mitochondrial calcium ion transport (GO:0006851) | 2.82482420 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 2.80579696 |
| 48 | carnitine transmembrane transport (GO:1902603) | 2.80347525 |
| 49 | positive regulation of lamellipodium assembly (GO:0010592) | 2.79017258 |
| 50 | carnitine transport (GO:0015879) | 2.78981433 |
| 51 | amino-acid betaine transport (GO:0015838) | 2.78981433 |
| 52 | fatty acid catabolic process (GO:0009062) | 2.76832488 |
| 53 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.75052333 |
| 54 | fatty acid oxidation (GO:0019395) | 2.74359374 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73933269 |
| 56 | translational termination (GO:0006415) | 2.73219817 |
| 57 | cellular response to interleukin-15 (GO:0071350) | 2.72956752 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71512326 |
| 59 | positive regulation of defense response to virus by host (GO:0002230) | 2.71135840 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.71057494 |
| 61 | piRNA metabolic process (GO:0034587) | 2.70318725 |
| 62 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69903355 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69399623 |
| 64 | response to protozoan (GO:0001562) | 2.69121609 |
| 65 | purine-containing compound salvage (GO:0043101) | 2.69111127 |
| 66 | lipid oxidation (GO:0034440) | 2.68669296 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68415777 |
| 68 | immunoglobulin mediated immune response (GO:0016064) | 2.68191102 |
| 69 | toxin transport (GO:1901998) | 2.67909525 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 2.67743621 |
| 71 | cellular response to interferon-beta (GO:0035458) | 2.67295091 |
| 72 | mast cell activation (GO:0045576) | 2.63963239 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.63160903 |
| 74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.62332519 |
| 75 | pinocytosis (GO:0006907) | 2.61945683 |
| 76 | response to interferon-alpha (GO:0035455) | 2.61825295 |
| 77 | quaternary ammonium group transport (GO:0015697) | 2.61699718 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61166028 |
| 79 | NADPH regeneration (GO:0006740) | 2.60555204 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.60344651 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.60344651 |
| 82 | response to type I interferon (GO:0034340) | 2.59680082 |
| 83 | detection of bacterium (GO:0016045) | 2.59351902 |
| 84 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.59189176 |
| 85 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.59128437 |
| 86 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.58892706 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.58457181 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.57308881 |
| 89 | respiratory electron transport chain (GO:0022904) | 2.56866528 |
| 90 | positive T cell selection (GO:0043368) | 2.56752167 |
| 91 | response to thyroid hormone (GO:0097066) | 2.55231596 |
| 92 | regulation of cholesterol storage (GO:0010885) | 2.54770833 |
| 93 | respiratory burst (GO:0045730) | 2.54582790 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.54454420 |
| 95 | alpha-linolenic acid metabolic process (GO:0036109) | 2.54435146 |
| 96 | protein complex biogenesis (GO:0070271) | 2.53241999 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51823443 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.50872400 |
| 99 | translational elongation (GO:0006414) | 2.50553082 |
| 100 | ADP metabolic process (GO:0046031) | 2.50180611 |
| 101 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.49556349 |
| 102 | pseudouridine synthesis (GO:0001522) | 2.48959930 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 2.48266951 |
| 104 | GDP-mannose metabolic process (GO:0019673) | 2.47598245 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 2.47129658 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 2.47016582 |
| 107 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.46807693 |
| 108 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.46807693 |
| 109 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.46638202 |
| 110 | ribosomal small subunit biogenesis (GO:0042274) | 2.46254100 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.46011847 |
| 112 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.45660001 |
| 113 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.45243310 |
| 114 | electron transport chain (GO:0022900) | 2.44807713 |
| 115 | response to peptidoglycan (GO:0032494) | 2.44188489 |
| 116 | positive regulation of interferon-alpha production (GO:0032727) | 2.44111066 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42836665 |
| 118 | mature B cell differentiation involved in immune response (GO:0002313) | 2.42682315 |
| 119 | angiogenesis involved in wound healing (GO:0060055) | 2.42644254 |
| 120 | DNA methylation involved in gamete generation (GO:0043046) | 2.42275417 |
| 121 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.41915481 |
| 122 | actin nucleation (GO:0045010) | 2.41303426 |
| 123 | deoxyribose phosphate catabolic process (GO:0046386) | 2.40945882 |
| 124 | regulation of relaxation of muscle (GO:1901077) | 2.39367672 |
| 125 | detection of other organism (GO:0098543) | 2.39335221 |
| 126 | barbed-end actin filament capping (GO:0051016) | 2.39332575 |
| 127 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.39311138 |
| 128 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.39311138 |
| 129 | NADH dehydrogenase complex assembly (GO:0010257) | 2.39311138 |
| 130 | defense response to protozoan (GO:0042832) | 2.38920020 |
| 131 | response to interleukin-15 (GO:0070672) | 2.38034301 |
| 132 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.37811416 |
| 133 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.36698185 |
| 134 | T cell apoptotic process (GO:0070231) | 2.35349719 |
| 135 | monocarboxylic acid catabolic process (GO:0072329) | 2.34864979 |
| 136 | necroptotic process (GO:0070266) | 2.34857050 |
| 137 | sarcomere organization (GO:0045214) | 2.34349439 |
| 138 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.34222064 |
| 139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33056480 |
| 140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33056480 |
| 141 | modulation by symbiont of host immune response (GO:0052553) | 2.33056480 |
| 142 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33056480 |
| 143 | modulation by symbiont of host defense response (GO:0052031) | 2.33056480 |
| 144 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33056480 |
| 145 | * platelet dense granule organization (GO:0060155) | 2.32276519 |
| 146 | aerobic respiration (GO:0009060) | 2.32148546 |
| 147 | regulation of respiratory burst (GO:0060263) | 2.32011399 |
| 148 | deoxyribonucleotide catabolic process (GO:0009264) | 2.30891140 |
| 149 | regulation of B cell apoptotic process (GO:0002902) | 2.30868887 |
| 150 | regulation of mast cell degranulation (GO:0043304) | 2.30840410 |
| 151 | succinate metabolic process (GO:0006105) | 2.30698424 |
| 152 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.30647395 |
| 153 | regulation of coenzyme metabolic process (GO:0051196) | 2.30497229 |
| 154 | regulation of cofactor metabolic process (GO:0051193) | 2.30497229 |
| 155 | glucose 6-phosphate metabolic process (GO:0051156) | 2.30373675 |
| 156 | nucleotide salvage (GO:0043173) | 2.29876903 |
| 157 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.29851881 |
| 158 | positive regulation of lamellipodium organization (GO:1902745) | 2.29371777 |
| 159 | metallo-sulfur cluster assembly (GO:0031163) | 2.29325085 |
| 160 | iron-sulfur cluster assembly (GO:0016226) | 2.29325085 |
| 161 | megakaryocyte development (GO:0035855) | 2.29136820 |
| 162 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.28881751 |
| 163 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.28741528 |
| 164 | regulation of interferon-alpha production (GO:0032647) | 2.28456535 |
| 165 | negative regulation of interleukin-17 production (GO:0032700) | 2.28074743 |
| 166 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.28014290 |
| 167 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.27825094 |
| 168 | negative regulation of type I interferon production (GO:0032480) | 2.27703832 |
| 169 | cytochrome complex assembly (GO:0017004) | 2.27556219 |
| 170 | purine nucleotide salvage (GO:0032261) | 2.27370067 |
| 171 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.27227418 |
| 172 | respiratory chain complex IV assembly (GO:0008535) | 2.26618119 |
| 173 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.26360718 |
| 174 | positive regulation of protein homooligomerization (GO:0032464) | 2.25389643 |
| 175 | interferon-gamma production (GO:0032609) | 2.24753528 |
| 176 | base-excision repair, AP site formation (GO:0006285) | 2.24745891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.49783668 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47711781 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.47134394 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.40573984 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.29410529 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.89715128 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86137920 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72004197 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67968705 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64419212 |
| 11 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59505690 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.54963647 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50909145 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50770296 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34276759 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14197922 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12810432 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12526035 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.12334031 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09708747 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.09173982 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07481897 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03682992 |
| 24 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02639485 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93869302 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.91540663 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89669733 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.88898772 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.87869560 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87335019 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85501528 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.85193685 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.85132370 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83746920 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83718129 |
| 36 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80540108 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.77990670 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76948645 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.74771667 |
| 40 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71808215 |
| 41 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.66988519 |
| 42 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.65624361 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65609950 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65058924 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64504272 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.63064629 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62086462 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61822346 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.61812010 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61767420 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61595462 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.60662106 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60532292 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60452381 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.58940482 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54648934 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53158140 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52938794 |
| 59 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.51729191 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50652506 |
| 61 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50569500 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49731035 |
| 63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.49693798 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48725813 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48528437 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47984485 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.44784571 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.44454857 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43518492 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42677525 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41535035 |
| 72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40869354 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38787369 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38024856 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37009442 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36146127 |
| 77 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36081283 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35833280 |
| 79 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35709774 |
| 80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35288010 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33020290 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31811979 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.30304118 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.30226929 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30062070 |
| 86 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28016297 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27662007 |
| 88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26401946 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26294737 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25414383 |
| 91 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.25213121 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23197076 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22504030 |
| 94 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22482507 |
| 95 | MYB_26560356_Chip-Seq_TH1_Human | 1.21166916 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20222998 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20215596 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.20131838 |
| 99 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.19016632 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17952757 |
| 101 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17480108 |
| 102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17083185 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16433601 |
| 104 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16293433 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16203228 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15814469 |
| 107 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15422956 |
| 108 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14221322 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11415960 |
| 110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.10848542 |
| 111 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10368641 |
| 112 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09878902 |
| 113 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09684593 |
| 114 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09250318 |
| 115 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09022582 |
| 116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08061570 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07978041 |
| 118 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07441854 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06059071 |
| 120 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05065851 |
| 121 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04337576 |
| 122 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03949767 |
| 123 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.03674329 |
| 124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03407812 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01881750 |
| 126 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00440762 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00161652 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 0.98072947 |
| 129 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.96891458 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96395241 |
| 131 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96087219 |
| 132 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.95063539 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94314400 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94004930 |
| 135 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93948754 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93674445 |
| 137 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93244122 |
| 138 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91970604 |
| 139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91614835 |
| 140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91111810 |
| 141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91093516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000015_abnormal_ear_pigmentation | 3.21603115 |
| 2 | MP0003646_muscle_fatigue | 3.18572788 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 2.75322194 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 2.66732389 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.57357419 |
| 6 | MP0003436_decreased_susceptibility_to | 2.42259369 |
| 7 | MP0000751_myopathy | 2.36022534 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.28706949 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.25036442 |
| 10 | MP0009785_altered_susceptibility_to | 2.22933033 |
| 11 | MP0004510_myositis | 2.18839274 |
| 12 | MP0009840_abnormal_foam_cell | 2.15654267 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.14827237 |
| 14 | MP0003724_increased_susceptibility_to | 2.09958752 |
| 15 | MP0003303_peritoneal_inflammation | 2.09046164 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.07891962 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.05557128 |
| 18 | MP0004130_abnormal_muscle_cell | 2.04035647 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.01682087 |
| 20 | MP0000343_altered_response_to | 1.99562792 |
| 21 | MP0000372_irregular_coat_pigmentation | 1.99228905 |
| 22 | MP0002132_abnormal_respiratory_system | 1.95487736 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.93238291 |
| 24 | * MP0005464_abnormal_platelet_physiology | 1.91057215 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.90907207 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.89710219 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.89410069 |
| 28 | MP0001853_heart_inflammation | 1.89070801 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.84565591 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.84565591 |
| 31 | MP0002419_abnormal_innate_immunity | 1.84249577 |
| 32 | * MP0005025_abnormal_response_to | 1.81061735 |
| 33 | MP0005360_urolithiasis | 1.77777946 |
| 34 | MP0000685_abnormal_immune_system | 1.75665164 |
| 35 | MP0003787_abnormal_imprinting | 1.75270169 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.73872072 |
| 37 | MP0005330_cardiomyopathy | 1.66963040 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.66534701 |
| 39 | MP0008260_abnormal_autophagy | 1.66219456 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.61652813 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.60553745 |
| 42 | MP0008877_abnormal_DNA_methylation | 1.58817708 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.53342827 |
| 44 | MP0003075_altered_response_to | 1.51748187 |
| 45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49315656 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.48166679 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.47942554 |
| 48 | MP0008469_abnormal_protein_level | 1.46553047 |
| 49 | MP0004147_increased_porphyrin_level | 1.44972118 |
| 50 | MP0009278_abnormal_bone_marrow | 1.44927567 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.44074408 |
| 52 | MP0002723_abnormal_immune_serum | 1.41622432 |
| 53 | MP0000749_muscle_degeneration | 1.41403395 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.40801166 |
| 55 | MP0005365_abnormal_bile_salt | 1.39432717 |
| 56 | MP0008058_abnormal_DNA_repair | 1.38936494 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.38343737 |
| 58 | MP0005451_abnormal_body_composition | 1.37891213 |
| 59 | MP0004036_abnormal_muscle_relaxation | 1.36347813 |
| 60 | MP0001800_abnormal_humoral_immune | 1.35516066 |
| 61 | MP0003828_pulmonary_edema | 1.35094577 |
| 62 | * MP0002420_abnormal_adaptive_immunity | 1.34830739 |
| 63 | MP0005174_abnormal_tail_pigmentation | 1.34466549 |
| 64 | MP0006082_CNS_inflammation | 1.34270714 |
| 65 | * MP0001819_abnormal_immune_cell | 1.34137124 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.33340613 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33119591 |
| 68 | MP0003186_abnormal_redox_activity | 1.31745458 |
| 69 | MP0002095_abnormal_skin_pigmentation | 1.31699897 |
| 70 | MP0004087_abnormal_muscle_fiber | 1.30996503 |
| 71 | MP0004233_abnormal_muscle_weight | 1.27845206 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.24418698 |
| 73 | MP0005385_cardiovascular_system_phenoty | 1.24036563 |
| 74 | MP0001544_abnormal_cardiovascular_syste | 1.24036563 |
| 75 | * MP0002398_abnormal_bone_marrow | 1.23986357 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.23849313 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.22531997 |
| 78 | MP0005166_decreased_susceptibility_to | 1.21680460 |
| 79 | MP0001790_abnormal_immune_system | 1.21375070 |
| 80 | MP0005387_immune_system_phenotype | 1.21375070 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19435762 |
| 82 | MP0004215_abnormal_myocardial_fiber | 1.19141649 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.18827504 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.17619335 |
| 85 | MP0003866_abnormal_defecation | 1.17144985 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 1.17096796 |
| 87 | MP0000716_abnormal_immune_system | 1.15448767 |
| 88 | MP0004484_altered_response_of | 1.15408981 |
| 89 | MP0008438_abnormal_cutaneous_collagen | 1.12155634 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 1.11939847 |
| 91 | MP0010630_abnormal_cardiac_muscle | 1.11563842 |
| 92 | MP0002405_respiratory_system_inflammati | 1.11230785 |
| 93 | MP0005332_abnormal_amino_acid | 1.11048176 |
| 94 | MP0000609_abnormal_liver_physiology | 1.10833373 |
| 95 | MP0005083_abnormal_biliary_tract | 1.10655260 |
| 96 | * MP0002429_abnormal_blood_cell | 1.08860089 |
| 97 | MP0002722_abnormal_immune_system | 1.08402772 |
| 98 | MP0003195_calcinosis | 1.08131728 |
| 99 | MP0009764_decreased_sensitivity_to | 1.07692998 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 1.04330153 |
| 101 | MP0003878_abnormal_ear_physiology | 1.04330153 |
| 102 | MP0003279_aneurysm | 1.03960272 |
| 103 | MP0003252_abnormal_bile_duct | 1.02692852 |
| 104 | MP0002106_abnormal_muscle_physiology | 1.02309209 |
| 105 | MP0010155_abnormal_intestine_physiology | 1.01865043 |
| 106 | MP0001905_abnormal_dopamine_level | 1.00639939 |
| 107 | MP0010094_abnormal_chromosome_stability | 1.00450156 |
| 108 | MP0001919_abnormal_reproductive_system | 1.00228764 |
| 109 | MP0005310_abnormal_salivary_gland | 0.99591182 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.99478873 |
| 111 | MP0001764_abnormal_homeostasis | 0.99385294 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.99180921 |
| 113 | MP0003705_abnormal_hypodermis_morpholog | 0.98962945 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.98903576 |
| 115 | MP0002006_tumorigenesis | 0.98034125 |
| 116 | MP0001188_hyperpigmentation | 0.98012835 |
| 117 | MP0003879_abnormal_hair_cell | 0.97874862 |
| 118 | MP0002972_abnormal_cardiac_muscle | 0.97593196 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.96808102 |
| 120 | MP0000858_altered_metastatic_potential | 0.96752292 |
| 121 | MP0000598_abnormal_liver_morphology | 0.94833323 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.94637108 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.93702614 |
| 124 | MP0005535_abnormal_body_temperature | 0.93521153 |
| 125 | MP0000249_abnormal_blood_vessel | 0.91913682 |
| 126 | MP0005671_abnormal_response_to | 0.91622462 |
| 127 | MP0005670_abnormal_white_adipose | 0.91532114 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.91217729 |
| 129 | MP0002971_abnormal_brown_adipose | 0.90580412 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.89610662 |
| 131 | MP0003786_premature_aging | 0.89338341 |
| 132 | MP0009115_abnormal_fat_cell | 0.88505162 |
| 133 | MP0001958_emphysema | 0.88194865 |
| 134 | MP0002277_abnormal_respiratory_mucosa | 0.87255334 |
| 135 | MP0009046_muscle_twitch | 0.83325445 |
| 136 | MP0004947_skin_inflammation | 0.81851845 |
| 137 | MP0004742_abnormal_vestibular_system | 0.81000564 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.79180989 |
| 139 | MP0005389_reproductive_system_phenotype | 0.77656063 |
| 140 | MP0001727_abnormal_embryo_implantation | 0.77202253 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.77141161 |
| 142 | MP0002163_abnormal_gland_morphology | 0.74802559 |
| 143 | MP0000313_abnormal_cell_death | 0.74618636 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.74402049 |
| 145 | MP0001501_abnormal_sleep_pattern | 0.74227224 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.74056848 |
| 147 | MP0004381_abnormal_hair_follicle | 0.73042451 |
| 148 | MP0002272_abnormal_nervous_system | 0.72095817 |
| 149 | MP0000358_abnormal_cell_content/ | 0.71889185 |
| 150 | MP0008874_decreased_physiological_sensi | 0.70698061 |
| 151 | MP0002210_abnormal_sex_determination | 0.69979437 |
| 152 | MP0009379_abnormal_foot_pigmentation | 0.66812804 |
| 153 | MP0003111_abnormal_nucleus_morphology | 0.66293828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 3.92596519 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 3.77435771 |
| 3 | Asymmetric septal hypertrophy (HP:0001670) | 3.56271626 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.38408121 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35424586 |
| 6 | Myoglobinuria (HP:0002913) | 3.32721903 |
| 7 | Combined immunodeficiency (HP:0005387) | 3.31703455 |
| 8 | Thrombocytosis (HP:0001894) | 3.30392915 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.27804050 |
| 10 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23047584 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.11237888 |
| 12 | Myositis (HP:0100614) | 3.10247843 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.04391504 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.04391504 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.04391504 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.99051193 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 2.98887206 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 2.95381189 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.93314866 |
| 20 | Methylmalonic aciduria (HP:0012120) | 2.92312689 |
| 21 | Meningitis (HP:0001287) | 2.91674152 |
| 22 | Obstructive lung disease (HP:0006536) | 2.90089624 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90089624 |
| 24 | Recurrent fungal infections (HP:0002841) | 2.86815690 |
| 25 | Hepatic necrosis (HP:0002605) | 2.84927230 |
| 26 | B lymphocytopenia (HP:0010976) | 2.84216119 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.84208253 |
| 28 | Hypoplasia of the thymus (HP:0000778) | 2.82756032 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.80453699 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.79172651 |
| 31 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.78313728 |
| 32 | Rhabdomyolysis (HP:0003201) | 2.76925832 |
| 33 | Nausea (HP:0002018) | 2.76352330 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.76057457 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.72282529 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71352613 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.70031771 |
| 38 | Nasal polyposis (HP:0100582) | 2.66487185 |
| 39 | Stomatitis (HP:0010280) | 2.66185892 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.62433315 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61999378 |
| 42 | Exertional dyspnea (HP:0002875) | 2.60482320 |
| 43 | Lipid accumulation in hepatocytes (HP:0006561) | 2.57492801 |
| 44 | Axonal loss (HP:0003447) | 2.56325038 |
| 45 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.56113215 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.55619107 |
| 47 | Sudden death (HP:0001699) | 2.54459615 |
| 48 | Granulocytopenia (HP:0001913) | 2.54222715 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.52106918 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.50650726 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.48306940 |
| 52 | Progressive macrocephaly (HP:0004481) | 2.47300781 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.43772783 |
| 54 | Optic neuritis (HP:0100653) | 2.43772783 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.43483472 |
| 56 | Respiratory difficulties (HP:0002880) | 2.42887283 |
| 57 | Hyperammonemia (HP:0001987) | 2.42300750 |
| 58 | Ventricular tachycardia (HP:0004756) | 2.41771302 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.38148458 |
| 60 | IgG deficiency (HP:0004315) | 2.37587505 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.37274819 |
| 62 | Abnormality of macrophages (HP:0004311) | 2.37027516 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36892695 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36577988 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36577988 |
| 66 | Tetany (HP:0001281) | 2.36330221 |
| 67 | Palpitations (HP:0001962) | 2.35281038 |
| 68 | Recurrent skin infections (HP:0001581) | 2.34548872 |
| 69 | Increased serum ferritin (HP:0003281) | 2.34524878 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33428711 |
| 71 | Orchitis (HP:0100796) | 2.33088673 |
| 72 | Hypertensive crisis (HP:0100735) | 2.31919973 |
| 73 | Lipoatrophy (HP:0100578) | 2.31411649 |
| 74 | Thyroiditis (HP:0100646) | 2.30939255 |
| 75 | Petechiae (HP:0000967) | 2.30003194 |
| 76 | Hypokinesia (HP:0002375) | 2.29774548 |
| 77 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29746981 |
| 78 | Subaortic stenosis (HP:0001682) | 2.29746981 |
| 79 | Abnormality of magnesium homeostasis (HP:0004921) | 2.27035061 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25377391 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.25377391 |
| 82 | Hypomagnesemia (HP:0002917) | 2.24876186 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 2.24266719 |
| 84 | Neoplasm of head and neck (HP:0012288) | 2.22695140 |
| 85 | Esophageal neoplasm (HP:0100751) | 2.22695140 |
| 86 | Abnormality of T cells (HP:0002843) | 2.21976692 |
| 87 | * Abnormal platelet function (HP:0011869) | 2.21163915 |
| 88 | * Impaired platelet aggregation (HP:0003540) | 2.21163915 |
| 89 | Encephalitis (HP:0002383) | 2.20712403 |
| 90 | Ketosis (HP:0001946) | 2.19594981 |
| 91 | Recurrent viral infections (HP:0004429) | 2.13758611 |
| 92 | Systemic lupus erythematosus (HP:0002725) | 2.13460446 |
| 93 | Exercise intolerance (HP:0003546) | 2.13104153 |
| 94 | Conjunctival hamartoma (HP:0100780) | 2.12471979 |
| 95 | Loss of speech (HP:0002371) | 2.10725145 |
| 96 | Lactic acidosis (HP:0003128) | 2.10422079 |
| 97 | Abnormality of eosinophils (HP:0001879) | 2.09252275 |
| 98 | Hyperthyroidism (HP:0000836) | 2.09048392 |
| 99 | Arterial thrombosis (HP:0004420) | 2.08991437 |
| 100 | T lymphocytopenia (HP:0005403) | 2.07484899 |
| 101 | Exercise-induced myalgia (HP:0003738) | 2.07145978 |
| 102 | Epistaxis (HP:0000421) | 2.06202128 |
| 103 | IgM deficiency (HP:0002850) | 2.05496305 |
| 104 | Atrioventricular block (HP:0001678) | 2.04797354 |
| 105 | Bundle branch block (HP:0011710) | 2.04632273 |
| 106 | Cellulitis (HP:0100658) | 2.03853023 |
| 107 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.03725924 |
| 108 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.03725924 |
| 109 | Increased serum lactate (HP:0002151) | 2.03340274 |
| 110 | Chronic otitis media (HP:0000389) | 2.02373208 |
| 111 | Abnormality of alanine metabolism (HP:0010916) | 2.01701243 |
| 112 | Hyperalaninemia (HP:0003348) | 2.01701243 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.01701243 |
| 114 | Atrial fibrillation (HP:0005110) | 2.01545106 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.01361357 |
| 116 | Ketoacidosis (HP:0001993) | 2.00548509 |
| 117 | Multiple enchondromatosis (HP:0005701) | 1.97863891 |
| 118 | Eosinophilia (HP:0001880) | 1.97843755 |
| 119 | Supraventricular tachycardia (HP:0004755) | 1.96918532 |
| 120 | Vasculitis (HP:0002633) | 1.95591668 |
| 121 | Microretrognathia (HP:0000308) | 1.94959354 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 1.94855224 |
| 123 | Increased connective tissue (HP:0009025) | 1.94562738 |
| 124 | Primary atrial arrhythmia (HP:0001692) | 1.94107312 |
| 125 | Supraventricular arrhythmia (HP:0005115) | 1.93538775 |
| 126 | Joint hemorrhage (HP:0005261) | 1.93312164 |
| 127 | Gastrointestinal stroma tumor (HP:0100723) | 1.93204026 |
| 128 | Leukocytosis (HP:0001974) | 1.93015872 |
| 129 | Xanthomatosis (HP:0000991) | 1.92535175 |
| 130 | Progressive muscle weakness (HP:0003323) | 1.92445368 |
| 131 | Degeneration of anterior horn cells (HP:0002398) | 1.91232085 |
| 132 | Abnormality of the anterior horn cell (HP:0006802) | 1.91232085 |
| 133 | Neurodegeneration (HP:0002180) | 1.90819555 |
| 134 | Dysostosis multiplex (HP:0000943) | 1.90055240 |
| 135 | Aplastic anemia (HP:0001915) | 1.89521764 |
| 136 | Skin rash (HP:0000988) | 1.89395372 |
| 137 | Muscle fiber splitting (HP:0003555) | 1.88818654 |
| 138 | Increased CSF lactate (HP:0002490) | 1.87401037 |
| 139 | Abnormality of the thymus (HP:0000777) | 1.86793452 |
| 140 | Limb-girdle muscle atrophy (HP:0003797) | 1.86478640 |
| 141 | Vertebral compression fractures (HP:0002953) | 1.86212469 |
| 142 | Acute hepatic failure (HP:0006554) | 1.86209616 |
| 143 | Abnormality of T cell number (HP:0011839) | 1.85505771 |
| 144 | Abnormal number of erythroid precursors (HP:0012131) | 1.85241255 |
| 145 | Purpura (HP:0000979) | 1.84988716 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.84881802 |
| 147 | Cholecystitis (HP:0001082) | 1.84881802 |
| 148 | Hypertriglyceridemia (HP:0002155) | 1.84562468 |
| 149 | Menorrhagia (HP:0000132) | 1.84142451 |
| 150 | Mitochondrial inheritance (HP:0001427) | 1.83783622 |
| 151 | Acute encephalopathy (HP:0006846) | 1.83342944 |
| 152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81860609 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.81860609 |
| 154 | Sepsis (HP:0100806) | 1.80878289 |
| 155 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80868822 |
| 156 | Bone cyst (HP:0012062) | 1.80835267 |
| 157 | Abnormality of DNA repair (HP:0003254) | 1.80120316 |
| 158 | Abnormality of T cell physiology (HP:0011840) | 1.79995119 |
| 159 | Increased IgM level (HP:0003496) | 1.77956105 |
| 160 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77954903 |
| 161 | Interstitial pulmonary disease (HP:0006530) | 1.77629506 |
| 162 | Progressive microcephaly (HP:0000253) | 1.77560159 |
| 163 | Hypercholesterolemia (HP:0003124) | 1.77284211 |
| 164 | Lymphopenia (HP:0001888) | 1.77073161 |
| 165 | Cerebral hypomyelination (HP:0006808) | 1.76934252 |
| 166 | Hyperglycinuria (HP:0003108) | 1.76513611 |
| 167 | Urticaria (HP:0001025) | 1.76317794 |
| 168 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.76277653 |
| 169 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.75824061 |
| 170 | Cerebral edema (HP:0002181) | 1.75585443 |
| 171 | Thoracic kyphosis (HP:0002942) | 1.75349613 |
| 172 | Anorexia (HP:0002039) | 1.75230284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 3.67699132 |
| 2 | TRIB3 | 3.45798914 |
| 3 | TESK2 | 3.45770381 |
| 4 | NME2 | 2.99406337 |
| 5 | MAP4K1 | 2.59899534 |
| 6 | TXK | 2.57199048 |
| 7 | TTN | 2.56553453 |
| 8 | MAP3K12 | 2.54633544 |
| 9 | VRK2 | 2.50798308 |
| 10 | KIT | 2.42093238 |
| 11 | ERN1 | 2.35378755 |
| 12 | RIPK4 | 2.32159367 |
| 13 | BCKDK | 2.29200955 |
| 14 | PIM2 | 2.28575487 |
| 15 | TBK1 | 2.24989172 |
| 16 | MYLK | 2.01502107 |
| 17 | MAP2K3 | 1.83992189 |
| 18 | MAP3K11 | 1.63447219 |
| 19 | BLK | 1.62060938 |
| 20 | FLT3 | 1.61068277 |
| 21 | PDK4 | 1.57913852 |
| 22 | PDK3 | 1.57913852 |
| 23 | SIK3 | 1.57701238 |
| 24 | MARK3 | 1.56690141 |
| 25 | TGFBR2 | 1.54588421 |
| 26 | BTK | 1.52077049 |
| 27 | TNK2 | 1.50973536 |
| 28 | DAPK1 | 1.50588831 |
| 29 | MUSK | 1.49156776 |
| 30 | SIK2 | 1.47991768 |
| 31 | TESK1 | 1.45846590 |
| 32 | IRAK3 | 1.42548494 |
| 33 | CSF1R | 1.39173876 |
| 34 | ZAP70 | 1.35921301 |
| 35 | SCYL2 | 1.35402200 |
| 36 | STK16 | 1.35244963 |
| 37 | LMTK2 | 1.32838784 |
| 38 | EEF2K | 1.32560608 |
| 39 | SYK | 1.32382048 |
| 40 | ILK | 1.28560699 |
| 41 | KDR | 1.28024766 |
| 42 | PRKG2 | 1.27788577 |
| 43 | NUAK1 | 1.22778006 |
| 44 | PINK1 | 1.20156679 |
| 45 | LRRK2 | 1.17862936 |
| 46 | TEC | 1.17854115 |
| 47 | TGFBR1 | 1.15489692 |
| 48 | TLK1 | 1.14478551 |
| 49 | NEK1 | 1.10138691 |
| 50 | CAMKK2 | 1.07698007 |
| 51 | PAK4 | 1.07155797 |
| 52 | TIE1 | 1.06792373 |
| 53 | TYK2 | 1.06767906 |
| 54 | GRK5 | 1.04147215 |
| 55 | PRKCQ | 1.02871502 |
| 56 | RAF1 | 1.01631330 |
| 57 | DAPK3 | 1.00398159 |
| 58 | CDK19 | 0.99590054 |
| 59 | ABL2 | 0.98902317 |
| 60 | IRAK4 | 0.98425794 |
| 61 | CAMKK1 | 0.95846827 |
| 62 | IKBKE | 0.94480743 |
| 63 | NEK9 | 0.93143730 |
| 64 | RIPK1 | 0.92902999 |
| 65 | BUB1 | 0.89898786 |
| 66 | BRAF | 0.89606540 |
| 67 | MAP3K13 | 0.87691719 |
| 68 | AURKA | 0.85452910 |
| 69 | CSK | 0.83945408 |
| 70 | EIF2AK1 | 0.83520463 |
| 71 | JAK3 | 0.83368493 |
| 72 | PIM1 | 0.82070175 |
| 73 | IKBKB | 0.80320281 |
| 74 | RPS6KA6 | 0.78626540 |
| 75 | MAP3K10 | 0.78267696 |
| 76 | ALK | 0.77270415 |
| 77 | MAP3K3 | 0.76968039 |
| 78 | CDK9 | 0.76568626 |
| 79 | FES | 0.75737695 |
| 80 | FGR | 0.74158425 |
| 81 | TAOK2 | 0.71740059 |
| 82 | TAOK3 | 0.71568490 |
| 83 | GRK6 | 0.71044314 |
| 84 | MAPK4 | 0.69585735 |
| 85 | MAP3K14 | 0.69474497 |
| 86 | MAP2K2 | 0.68249477 |
| 87 | WEE1 | 0.68018417 |
| 88 | PTK2B | 0.67481459 |
| 89 | HCK | 0.67420736 |
| 90 | ARAF | 0.66567444 |
| 91 | NTRK3 | 0.65935996 |
| 92 | PDK2 | 0.64876505 |
| 93 | JAK2 | 0.64223087 |
| 94 | PDPK1 | 0.63017672 |
| 95 | CSNK1G3 | 0.62823494 |
| 96 | MAP4K2 | 0.62758563 |
| 97 | SMG1 | 0.62657643 |
| 98 | LYN | 0.61531097 |
| 99 | JAK1 | 0.59597020 |
| 100 | MAP3K5 | 0.58549080 |
| 101 | MATK | 0.57663196 |
| 102 | RPS6KC1 | 0.57596646 |
| 103 | RPS6KL1 | 0.57596646 |
| 104 | NEK2 | 0.57066238 |
| 105 | MAPKAPK3 | 0.56669203 |
| 106 | DMPK | 0.56640671 |
| 107 | BRSK1 | 0.56371260 |
| 108 | MARK2 | 0.56267223 |
| 109 | PDK1 | 0.53931734 |
| 110 | VRK1 | 0.51461001 |
| 111 | PAK1 | 0.50778467 |
| 112 | RPS6KA4 | 0.50503269 |
| 113 | KSR2 | 0.50004665 |
| 114 | PTK6 | 0.49754481 |
| 115 | GRK7 | 0.49318481 |
| 116 | LIMK1 | 0.49050980 |
| 117 | PRPF4B | 0.46786519 |
| 118 | TAOK1 | 0.46156995 |
| 119 | MAP3K1 | 0.45937158 |
| 120 | MAPK11 | 0.45267924 |
| 121 | MAP3K7 | 0.45117930 |
| 122 | FGFR4 | 0.44379107 |
| 123 | STK4 | 0.44281540 |
| 124 | TRPM7 | 0.43518080 |
| 125 | PRKCI | 0.42021866 |
| 126 | PIK3CG | 0.41798418 |
| 127 | MAP3K6 | 0.41768887 |
| 128 | LCK | 0.41175149 |
| 129 | MST1R | 0.41160489 |
| 130 | BMX | 0.41156400 |
| 131 | STK24 | 0.39084394 |
| 132 | CAMK1 | 0.39044740 |
| 133 | DAPK2 | 0.38677926 |
| 134 | CSNK1G2 | 0.38447884 |
| 135 | PRKCD | 0.38438639 |
| 136 | NME1 | 0.38043822 |
| 137 | STK10 | 0.37378907 |
| 138 | HIPK2 | 0.36221561 |
| 139 | RPS6KA5 | 0.35914149 |
| 140 | MAPK12 | 0.35042669 |
| 141 | CSNK2A2 | 0.32737491 |
| 142 | ATR | 0.31413339 |
| 143 | CDK4 | 0.30842318 |
| 144 | MAP3K8 | 0.30330963 |
| 145 | AKT2 | 0.29883780 |
| 146 | MAPK3 | 0.29466895 |
| 147 | MST4 | 0.26534322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.80461840 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.31511373 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.20206277 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.12419651 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.48253596 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37784230 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31489339 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29237160 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22954409 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.20987924 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.14940519 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.03480211 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.00019364 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.98473695 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88408216 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.79876031 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79388127 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.79321629 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75020294 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63338153 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60264101 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.58787063 |
| 23 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.55789244 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54926053 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53679930 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52629485 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51951495 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49962727 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.48700978 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46651196 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43541504 |
| 32 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.41136887 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39767772 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37610352 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.35247726 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32939099 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31955613 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31609469 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31450729 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.31333117 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.31168901 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31047090 |
| 43 | RNA polymerase_Homo sapiens_hsa03020 | 1.28907022 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28404480 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23333977 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22847177 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22824465 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20309682 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.17613721 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16431217 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12534229 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.06953064 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05231798 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04523047 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.02985166 |
| 56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01961431 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00979273 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 0.99942220 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.98165970 |
| 60 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98104324 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96387750 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.95020892 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92901867 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92881082 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88809340 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88016430 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87713057 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87367002 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84563106 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84194854 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84074108 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83432447 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81398553 |
| 74 | Asthma_Homo sapiens_hsa05310 | 0.81185057 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.80515435 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79850783 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79766101 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79486084 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79148443 |
| 80 | RNA degradation_Homo sapiens_hsa03018 | 0.78334984 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78171085 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77130407 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.76484174 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.74129796 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.73588409 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73115364 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72894171 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69542935 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.69404902 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.69320329 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69222919 |
| 92 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68990427 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.68792379 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67851539 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67678519 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.67433539 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65749105 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.64574248 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64005946 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63780204 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63626353 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63343102 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.62550551 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.61317219 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61170935 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.61042140 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60648483 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60380998 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60283110 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59985719 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56819948 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.56384633 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.56286420 |
| 114 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55994885 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55470570 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55183620 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54845778 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54716401 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.52708138 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.52626201 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51875506 |
| 122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51159054 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48897393 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47990581 |
| 125 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47822936 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47112557 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46651746 |
| 128 | Mismatch repair_Homo sapiens_hsa03430 | 0.45840615 |
| 129 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45512620 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44025005 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43873331 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43758267 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43278518 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41146474 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.41139038 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40375631 |
| 137 | RNA transport_Homo sapiens_hsa03013 | 0.39255028 |
| 138 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39036553 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.37700123 |
| 140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.35336963 |
| 141 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34355597 |
| 142 | Influenza A_Homo sapiens_hsa05164 | 0.33693383 |
| 143 | Endocytosis_Homo sapiens_hsa04144 | 0.33338010 |

